ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Scanographic Exploration of Pancreatic Cancers: About 30 Cases

Journal: International Journal of Science and Research (IJSR) (Vol.8, No. 12)

Publication Date:

Authors : ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Page : 1438-1444

Keywords : pancreatic cancer; CT; resectability;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Introduction: 4th cause of cancer mortality and the 2nd cause of digestive cancer mortality after colorectal cancer, pancreatic cancer is a poor prognosis. The purpose of this work was to assess the role of the CT-scan in the diagnosis and resectable assessment of pancreatic tumors. Materials and methods: this was a retrospective, descriptive, bi-centric, one-year study involving 30 patients with a gender ratio of 2.33 in favour of men. The average age was 62.6 years with extremes of 42 and 82 years. The examinations were performed with a 64 and 16 slice scanner. We studied the morphological characteristics of the tumor and its resectability. Our data were analyzed with office 2007 and SPSS 22 statistics. We performed the Fischer test with a threshold value below 5 %. Results: the tumor was of cephalic site in 76.7 % of cases with a typical scanographic aspect that was hypodense at pancreatic time in 93.3 % of cases. The average tumor size was 37 mm, 6.7 % of patients had a tumor size less than 20 mm, 36.7 % had a size between 20 and 30 mm and 56.7 % had a size greater than 30 mm. Dilation of bile duct and IHBD was noted in 76.6 % of patients and dilation of Wirsung in 80 % of patients. Arterial contact was noted in 33.3 % of patients, venous contact in 46.7 % and retro-portal blade was invaded in 23.3 % of cases. Liver metastases occurred in 43 % of patients and peritoneal carcinosis in 30 %. The tumor was resectable in 20 % of patients, limited resectable in 6.6 %, locally advanced in 13.3 % and metastatic in 60 %. Conclusion: The CT made it possible to accurately characterize and assess the vascular and remote extension of pancreatic tumors that were potentially resectable in only 20 % of patients.

Last modified: 2021-06-28 18:33:10